Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Sorafenib in advanced hepatocellular carcinoma: a nationwide retrospective study of efficacy and tolerability

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Predictors of effects of lifestyle intervention on diabetes mellitus type 2 patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. High bone mineral density in lifelong trained female team handball players and young elite football players

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mineralocorticoid receptor antagonist improves cardiac structure in Type 2 Diabetes: Data from the MIRAD Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. One year of Football Fitness improves L1-L4 BMD, postural balance and muscle strength in women treated for breast cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Inflammatory diseases are often multiorganic diseases with manifestations not related directly to the primary affected organ. They are often complicated by a generalized bone loss that subsequently leads to osteoporosis and bone fractures. The exact mechanism for the accompanying bone loss is not understood in full detail, but factors such as glucocorticoid treatment, immobilization, malnutrition, and insufficient intake of vitamin D play a role. However, it has become evident that the inflammatory process itself is involved and the resulting bone loss is termed immune-mediated bone loss. It stems from an increase in bone resorption and the pro-inflammatory cytokines tumor necrosis factor alpha and interleukin 1 beta and has been shown to not only mediate the inflammatory response but also to strongly stimulate bone degradation. The purinergic P2X7 receptor is central in the processing of these two cytokines and in the initiation of the inflammatory response, and it is a key molecule in the regulation of both bone formation and bone resorption. The aim of this review is therefore to provide evidence-based novel hypotheses of the role of ATP-mediated purinergic signalling via the P2X7 receptor in immune-mediated bone loss and -osteoporosis.

OriginalsprogEngelsk
TidsskriftTheScientificWorldJournal
Vol/bind2014
Sider (fra-til)954530
ISSN1537-744X
DOI
StatusUdgivet - 2014

ID: 43540290